Momordica charantia

DRUG3 trials

Sponsors

Services Hospital, Lahore, University of Guadalajara

Conditions

Diabetes Mellitus Type 2ObesityType 2 Diabetes

Phase 2

Glycemic Response to Momordica Charantia in Type 2 Diabetes

WithdrawnNCT00823953

Services Hospital, LahoreType 2 Diabetes

Start: 2008-11-30End: 2009-02-28Updated: 2012-06-12

Effect of Momordica Charantia Administration on Type 2 Diabetes Mellitus, Insulin Sensitivity and Insulin Secretion

CompletedNCT02397447

University of GuadalajaraDiabetes Mellitus Type 2

Start: 2013-03-31End: 2015-11-30Updated: 2020-10-22

Unknown Phase

Effect of Momordica Charantia Administration on Anthropometric Indicators in Patients With Obesity

University of GuadalajaraObesity

Start: 2020-01-21End: 2021-09-30Updated: 2021-08-31

Related Papers

Effect of <i>Momordica charantia</i> Administration on Anthropometric Measures and Metabolic Profile in Patients with Obesity: A Pilot Clinical Trial

Journal of Medicinal Food2022-05-047 citations